Magnetic resonance imaging radiomics signatures for predicting endocrine resistance in hormone receptor-positive non-metastatic breast cancer

BACKGROUND: One-third of patients with hormone receptor (HR)-positive breast cancers fail to respond to hormone therapy, and some patients even progress within two years of adjuvant endocrine therapy (ET) toward primary endocrine resistance. However, there is no effective way to predict endocrine re...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yaping, Li, Junwei, Liu, Yajing, Zhong, Ying, Ren, Wei, Tan, Yujie, He, Zifan, Li, Chenchen, Ouyang, Jie, Hu, Qiugen, Yu, Yunfang, Yao, Herui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8449264/
https://www.ncbi.nlm.nih.gov/pubmed/34536884
http://dx.doi.org/10.1016/j.breast.2021.09.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8449264/
https://www.ncbi.nlm.nih.gov/pubmed/34536884
http://dx.doi.org/10.1016/j.breast.2021.09.005

Ejemplares similares